Chinese herbal preparation used for treating chronic viral hepatitis type b and taking method thereof

Abstract

The invention discloses a Chinese herbal preparation used for treating chronic viral hepatitis type b, comprising the following raw materials in percentage by weight: 4.5-10% of herba patriniae, 4.5-10% of coix seed, 4.5-5% of ginseng, 4.5-5% of white atractylodes rhizome, 4.5-5% of roasted milk vetch, 4.5-5% of eucommia bark, 9-10% of semen cuscutae, 1-2% of coptis chinensis, 2-3% of prepared pinellia ternate, 2-3% of dried tangerine or orange peel, 5-6% of white paeony root, 9-10% of prepared rehmannia root, 2.8-3.1% of salviae miltiorrhizae, 2.8-3.1% of safflower, 2.8-3.1% of peach kernel, 4-5% of liquorice, 2.8-3.1% of green tangerine peel, 6-6.5% of bupleurum, 4.5-5% of fingered citron, 9-10% of prepared turtle shell, 3-3.7% of poria cocos and 1.6-1.9% of rhizoma alismatis. The invention also provides a taking method of the Chinese herbal preparation. The Chinese herbal preparation disclosed by the invention has the advantages of good curative effect and no side effect, and the chronic viral hepatitis type b and a hepatitis B virus carrier can be fundamentally treated.

Description

technical field [0001] The invention belongs to a traditional Chinese medicine preparation, in particular to a traditional Chinese medicine preparation and a taking method for treating chronic hepatitis B disease. Background technique [0002] Hepatitis B virus, referred to as hepatitis B, is a disease caused by the infection of the body by the hepatitis B virus (HBV). Hepatitis B virus is a hepatotropic virus that mainly exists in liver cells and damages liver cells, causing inflammation, necrosis, and fibrosis of liver cells. Chronic hepatitis B has different manifestations, such as chronic hepatitis B carriers, chronic active hepatitis B, and hepatitis B cirrhosis. [0003] According to the report of the World Health Organization, about 2 billion people in the world have been infected with HBV, of which 350 million people are chronically infected, and about 1 million people die of HBV infection and related diseases every year. The results of the hepatitis B epidemic vir...

AI Technical Summary

Problems solved by technology

However, there are problems such as variability of treatment rules, uncertainty of curative effect, and poor repeatability.

Therefore, whether it is western medicine or traditional Chinese medicine, various antiviral drugs have their advantages and disadvantages. Generally speaking, the methods are increasing and the curative effect is constantly improving, but there is no breakthrough progress; Therefore, some experts put forward the view that "whoever can prevent / reverse liver fibrosis can treat most liver diseases", and thus infers that "who can really inhibit / clear hepatitis virus, who can can delay or prevent the occurrence and development of liver fibrosis

Images